Therapy (HCV)
"Pseudouridine for Monitoring Interferon Treatment of Patients with Chronic Hepatitis C."
Published in Hepatitis Weekly, October 28th, 1996
According to the authors' abstract of an article published in European Journal of Clinical Chemistry and Clinical Biochemistry, "Pseudouridine is a modified nucleoside derived from RNA catabolism; the concentration of this nucleoside is elevated in body fluids of both tumour-bearing and human immunodeficiency virus (HIV) infected patients. We used an HPLC procedure to evaluate the serum pseudouridine concentration in patients with chronic hepatitis C in an attempt to determine whether the nucleoside serum concentration was related to the response to a-interferon treatment. We found that: a) pseudouridine serum concentration was increased significantly in 76% (29/39) of patients with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1996-10-28)
More Articles from Hepatitis Weekly
- Disease Associations (HCV)
Hepatitis C May Be a Cause of Diabetes - Autoimmune Hepatitis
Recognition of Variant Forms Critical in Disease Treatment - Conference Coverage (ICAAC)
Six-Disease Vaccine Hailed as "Wave of Future" - Diagnostics (HCV)
Three Procedures Reliable in Genotyping Hepatitis C - HBV Vaccines
Lowering Dosage May Affect Long-Term Efficacy in Infants - Infection Control
Bacteria and Virus Passage Through Surgical Latex Gloves Confirmed - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
